Israel's Nano-X Imaging Q2 revenue misses estimates

Nano-X Imaging

09/09/2026 13:12

Overview
Israel medical imaging tech firm's Q2 revenue grew 37% yr/yr but missed analyst expectations
Adjusted net loss for Q2 missed analyst expectations
Company recorded $40.7 mln impairment charge related to AI solutions business unit

Outlook
Company expects Korea restructuring to generate annual cost savings of $2 mln starting in 2027
Company plans to continue raising funds to support operations and strengthen balance sheet
Company is pursuing a potential new CMS reimbursement pathway to support broader adoption

Result Drivers
HEALTH IT CONSOLIDATION - Revenue growth driven primarily by consolidation of Nanox Health IT business, which contributed $0.9 mln in Q2
IMPAIRMENT CHARGE - Co recorded $40.7 mln impairment charge related to AI solutions business unit, triggered by share price decline and reduced revenue forecasts
KOREA RESTRUCTURING - Co undertook restructuring of Korea operations, including workforce reduction and transition of chip manufacturing to third parties, expected to generate cost savings in 2027

Company press release: ID:nGNX6lLtSV

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
$4.20 mln
$5.39 mln (3 Analysts)
Q2 Adjusted Net Loss
Miss
$11.60 mln
$11.13 mln (3 Analysts)
Q2 Net Loss
 
$55.50 mln
 

Reuters Recommended Reads
Sept 9 - Oil producer Energean's H1 revenue falls, hurt by Israel production suspension
Sept 9 - Israel's Cognyte Q2 revenue rises on software demand
Sept 8 - Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)